AVDL logo

Avadel Pharmaceuticals plc (AVDL) Total assets

annual total assets:

$265.80M+$4.67M(+1.79%)
December 31, 2024

Summary

  • As of today (September 17, 2025), AVDL annual total assets is $265.80 million, with the most recent change of +$4.67 million (+1.79%) on December 31, 2024.
  • During the last 3 years, AVDL annual total assets has risen by +$18.54 million (+7.50%).
  • AVDL annual total assets is now -14.71% below its all-time high of $311.64 million, reached on December 31, 2020.

Performance

AVDL Total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLbalance sheet metrics

quarterly total assets:

$187.16M+$19.21M(+11.44%)
June 1, 2025

Summary

  • As of today (September 17, 2025), AVDL quarterly total assets is $187.16 million, with the most recent change of +$19.21 million (+11.44%) on June 1, 2025.
  • Over the past year, AVDL quarterly total assets has increased by +$29.64 million (+18.81%).
  • AVDL quarterly total assets is now -46.81% below its all-time high of $351.86 million, reached on March 31, 2018.

Performance

AVDL quarterly total assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLbalance sheet metrics

Total assets Formula

Total Assets = Current Assets + Non-Current Assets

AVDL Total assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+1.8%+18.8%
3 y3 years+7.5%+18.5%
5 y5 years+75.5%-45.2%

AVDL Total assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+30.2%-29.6%+33.0%
5 y5-year-14.7%+75.5%-45.2%+33.0%
alltimeall time-14.7%+1681.5%-46.8%+3882.1%

AVDL Total assets History

DateAnnualQuarterly
Jun 2025
-
$187.16M(+11.4%)
Mar 2025
-
$167.95M(-36.8%)
Dec 2024
$265.80M(+1.8%)
$265.80M(+68.0%)
Sep 2024
-
$158.25M(+0.5%)
Jun 2024
-
$157.52M(-6.2%)
Mar 2024
-
$167.90M(-35.7%)
Dec 2023
$261.13M(+27.9%)
$261.13M(+28.6%)
Sep 2023
-
$203.10M(+1.1%)
Jun 2023
-
$200.98M(+42.8%)
Mar 2023
-
$140.74M(-31.1%)
Dec 2022
$204.13M(-17.4%)
$204.13M(+40.0%)
Sep 2022
-
$145.76M(-7.7%)
Jun 2022
-
$157.94M(-28.6%)
Mar 2022
-
$221.13M(-10.6%)
Dec 2021
$247.26M(-20.7%)
$247.26M(-6.4%)
Sep 2021
-
$264.09M(-6.5%)
Jun 2021
-
$282.59M(-3.5%)
Mar 2021
-
$292.94M(-6.0%)
Dec 2020
$311.64M(+105.8%)
$311.64M(-4.9%)
Sep 2020
-
$327.63M(-4.0%)
Jun 2020
-
$341.40M(+64.4%)
Mar 2020
-
$207.72M(+37.2%)
Dec 2019
$151.44M(-20.4%)
$151.44M(-2.9%)
Sep 2019
-
$155.89M(-5.9%)
Jun 2019
-
$165.71M(-4.6%)
Mar 2019
-
$173.62M(-8.8%)
Dec 2018
$190.30M(-24.9%)
$190.30M(-29.3%)
Sep 2018
-
$269.01M(-8.9%)
Jun 2018
-
$295.24M(-16.1%)
Mar 2018
-
$351.86M(+38.9%)
Dec 2017
$253.28M(+3.2%)
$253.28M(-8.7%)
Sep 2017
-
$277.43M(+7.0%)
Jun 2017
-
$259.16M(+0.2%)
Mar 2017
-
$258.69M(+5.4%)
Dec 2016
$245.48M(+14.1%)
$245.48M(-1.0%)
Sep 2016
-
$247.99M(-0.4%)
Jun 2016
-
$249.01M(-2.4%)
Mar 2016
-
$255.01M(+16.3%)
Dec 2015
$215.08M(+23.5%)
$219.28M(+17.6%)
Mar 2015
-
$186.41M(+7.0%)
Dec 2014
$174.21M(+34.0%)
$174.21M(+6.0%)
Sep 2014
-
$164.39M(-5.9%)
Jun 2014
-
$174.63M(-3.9%)
Mar 2014
-
$181.74M(+39.8%)
DateAnnualQuarterly
Dec 2013
$129.98M(+10.8%)
$129.98M(+11.6%)
Sep 2013
-
$116.52M(-1.6%)
Jun 2013
-
$118.41M(-3.5%)
Mar 2013
-
$122.73M(+4.6%)
Dec 2012
$117.31M(+69.0%)
$117.31M(-12.3%)
Jun 2012
-
$133.72M(-2.7%)
Mar 2012
-
$137.41M(+98.0%)
Dec 2011
$69.40M(-7.0%)
$69.40M(-4.5%)
Sep 2011
-
$72.70M(-4.5%)
Jun 2011
-
$76.11M(+8.8%)
Mar 2011
-
$69.98M(-6.2%)
Dec 2010
$74.61M(-20.9%)
$74.61M(-3.6%)
Sep 2010
-
$77.38M(-17.9%)
Dec 2009
$94.30M(+2.7%)
$94.30M(+2.7%)
Dec 2008
$91.86M(-9.4%)
$91.86M(-9.4%)
Dec 2007
$101.40M(-11.7%)
$101.40M(-2.4%)
Sep 2007
-
$103.91M(-2.4%)
Jun 2007
-
$106.44M(-1.9%)
Mar 2007
-
$108.46M(-5.6%)
Dec 2006
$114.89M(-7.6%)
$114.89M(+1.1%)
Jun 2006
-
$113.65M(-2.3%)
Mar 2006
-
$116.28M(-6.5%)
Dec 2005
$124.35M(-14.6%)
$124.35M(-2.8%)
Sep 2005
-
$127.97M(-10.2%)
Jun 2005
-
$142.59M(-2.3%)
Mar 2005
-
$145.95M(+0.2%)
Dec 2004
$145.61M(+14.4%)
$145.61M(+16.0%)
Sep 2004
-
$125.57M(+1.1%)
Jun 2004
-
$124.23M(-2.6%)
Mar 2004
-
$127.59M(+0.3%)
Dec 2003
$127.25M(+451.4%)
$127.25M(+285.4%)
Sep 2003
-
$33.02M(+38.4%)
Jun 2003
-
$23.86M(+1.2%)
Mar 2003
-
$23.58M(+2.2%)
Dec 2002
$23.08M(+27.2%)
$23.08M(+6.5%)
Sep 2002
-
$21.67M(+19.5%)
Dec 2001
$18.14M(-10.9%)
$18.14M(-10.9%)
Dec 2000
$20.36M(+36.5%)
$20.36M(+36.5%)
Dec 1999
$14.92M(-41.1%)
$14.92M(-41.1%)
Dec 1998
$25.32M(+17.7%)
$25.32M(+34.0%)
Mar 1998
-
$18.90M(-12.1%)
Dec 1997
$21.51M(-28.1%)
$21.50M(-28.1%)
Dec 1996
$29.90M
$29.90M(+536.2%)
Mar 1996
-
$4.70M

FAQ

  • What is Avadel Pharmaceuticals plc annual total assets?
  • What is the all time high annual total assets for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc annual total assets year-on-year change?
  • What is Avadel Pharmaceuticals plc quarterly total assets?
  • What is the all time high quarterly total assets for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc quarterly total assets year-on-year change?

What is Avadel Pharmaceuticals plc annual total assets?

The current annual total assets of AVDL is $265.80M

What is the all time high annual total assets for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high annual total assets is $311.64M

What is Avadel Pharmaceuticals plc annual total assets year-on-year change?

Over the past year, AVDL annual total assets has changed by +$4.67M (+1.79%)

What is Avadel Pharmaceuticals plc quarterly total assets?

The current quarterly total assets of AVDL is $187.16M

What is the all time high quarterly total assets for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high quarterly total assets is $351.86M

What is Avadel Pharmaceuticals plc quarterly total assets year-on-year change?

Over the past year, AVDL quarterly total assets has changed by +$29.64M (+18.81%)
On this page